IRIS - Res&Arch Institutional Research Information System - Research & Archive

BECATTINI, Cecilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.371
AS - Asia 4.170
EU - Europa 3.751
SA - Sud America 920
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 14.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.255
SG - Singapore 1.934
IE - Irlanda 813
IT - Italia 773
BR - Brasile 765
HK - Hong Kong 655
CN - Cina 614
RU - Federazione Russa 545
VN - Vietnam 522
UA - Ucraina 347
DE - Germania 304
SE - Svezia 273
FI - Finlandia 218
KR - Corea 132
GB - Regno Unito 120
FR - Francia 98
TR - Turchia 64
AR - Argentina 57
AT - Austria 55
CA - Canada 52
IN - India 51
MX - Messico 48
PL - Polonia 43
BD - Bangladesh 37
NL - Olanda 31
EC - Ecuador 28
CH - Svizzera 27
ZA - Sudafrica 27
UZ - Uzbekistan 24
ES - Italia 23
IQ - Iraq 20
JP - Giappone 20
CL - Cile 16
CO - Colombia 14
LB - Libano 14
BE - Belgio 13
ID - Indonesia 13
VE - Venezuela 13
EG - Egitto 12
PE - Perù 12
LT - Lituania 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
CZ - Repubblica Ceca 9
MK - Macedonia 9
PY - Paraguay 9
TN - Tunisia 9
GR - Grecia 8
JO - Giordania 7
BG - Bulgaria 6
KE - Kenya 6
KG - Kirghizistan 5
RO - Romania 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
PH - Filippine 4
UY - Uruguay 4
AL - Albania 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DK - Danimarca 3
OM - Oman 3
PS - Palestinian Territory 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
KW - Kuwait 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
Totale 14.295
Salva come PNG Salva come JPEG
Città #
Singapore 1.234
Chandler 887
Dublin 809
Hong Kong 654
San Mateo 381
Dong Ket 295
Ashburn 271
Boardman 254
Santa Clara 237
Altamura 228
Perugia 225
Moscow 207
Medford 204
Princeton 200
Lawrence 194
Jacksonville 179
Beijing 143
Ann Arbor 133
Seoul 132
Wilmington 130
Munich 113
Los Angeles 112
Des Moines 107
Andover 103
Ho Chi Minh City 98
New York 86
São Paulo 72
Helsinki 62
Piscataway 61
Redmond 55
San Paolo di Civitate 53
Hanoi 47
The Dalles 44
Nuremberg 43
Saint Petersburg 42
Izmir 39
Turku 38
Norwalk 37
Dallas 34
Chicago 29
Shanghai 29
Brooklyn 27
Warsaw 27
Rio de Janeiro 26
Rome 26
Stockholm 26
Columbus 25
Hefei 25
Falls Church 24
Frankfurt am Main 22
Denver 20
Amelia 19
Boston 18
Atlanta 17
Redwood City 17
Tokyo 17
Houston 16
Johannesburg 16
Montreal 16
Vienna 15
Brasília 14
London 14
San Francisco 14
Toronto 14
Amsterdam 13
Woodbridge 13
Bologna 12
Brussels 12
Guarulhos 12
Orem 12
Phoenix 12
Seattle 12
Belo Horizonte 11
Chennai 11
Lappeenranta 11
Manchester 11
Quito 11
Tashkent 11
Curitiba 10
Falkenstein 10
Haiphong 10
Mexico City 10
Mumbai 10
Poplar 10
Ribeirão Preto 10
Zhengzhou 10
Salvador 9
Ancona 8
Bexley 8
Fortaleza 8
Goiânia 8
Hanover 8
Milan 8
San Jose 8
Amman 7
Ankara 7
Cairo 7
Campo Grande 7
Da Nang 7
Guayaquil 7
Totale 9.107
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 129
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 125
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 124
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 122
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 122
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 112
Aspirin for preventing the recurrence of venous thromboembolism. 106
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 103
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 100
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 100
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 96
A prospective study on cardiovascular events after acute pulmonary embolism 95
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 95
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 93
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 92
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 91
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 91
Initial treatment of venous thromboembolism 90
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 90
Acute pulmonary embolism: risk stratification in the emergency department. 90
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 89
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 89
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 89
Risk factors for adverse short-term outcome in patients with pulmonary embolism 88
Acute pulmonary embolism. 88
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 87
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 86
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 86
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 86
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 85
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 85
Acute pulmonary embolism: external validation of an integrated risk stratification model. 84
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 84
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 84
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 84
A new strategy for anticoagulation: The factor XI inhibitors 83
D-dimer for riskstratification in patients with acute pulmonary embolism. 83
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 83
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 82
New anticoagulants 82
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 82
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 82
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 82
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 81
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 81
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 80
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 80
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 80
Thrombolysis in submassive pulmonary embolism 80
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 79
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 78
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 77
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 77
Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY 77
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) 77
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 76
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 76
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 76
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 75
Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study 75
Combined oral anticoagulants and antiplatelets: benefits and risks. 74
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 74
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 74
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 74
Acute treatment of venous thromboembolism 74
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 74
Lo studio EINSTEIN CHOICE 74
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 73
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 73
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. 73
Pathogenesis of venous thromboembolism 72
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 72
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 72
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 72
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 72
Apixaban for the treatment of venous thromboembolism associated with cancer 72
Recurrent venous thromboembolism in men and women 71
ANMCO statement: Arterial and venous thromboembolism: What implications for clinical practice? 71
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism 70
Predictors of mortality from pulmonary embolism andtheir influence on clinical management. 70
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 70
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 70
Clinical and economic aspects of managing venous thromboembolism in the outpatient setting 70
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 69
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 69
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 69
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 69
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 69
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. 68
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 68
Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding 68
PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients-PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis 68
Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment 67
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 67
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. 66
Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis 66
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 66
Predicting Post-Thrombotic Syndrome with Ultrasonographic Follow-Up after Deep Vein Thrombosis: A Systematic Review and Meta-Analysis 65
Reply 64
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 63
Totale 8.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021619 0 0 0 0 0 40 72 17 80 41 64 305
2021/20221.566 27 259 20 50 81 19 14 457 52 111 220 256
2022/20233.014 221 658 38 206 233 347 0 110 1.063 13 91 34
2023/20241.065 80 110 71 15 12 5 261 32 67 59 212 141
2024/20253.289 24 270 89 152 383 253 140 258 685 214 525 296
2025/20263.655 588 520 428 953 981 185 0 0 0 0 0 0
Totale 14.796